552 related articles for article (PubMed ID: 31773180)
1. Characterisation of transcription factor profiles in polycystic kidney disease (PKD): identification and validation of STAT3 and RUNX1 in the injury/repair response and PKD progression.
Formica C; Malas T; Balog J; Verburg L; 't Hoen PAC; Peters DJM
J Mol Med (Berl); 2019 Dec; 97(12):1643-1656. PubMed ID: 31773180
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of polycystic kidney disease expression profiles defines strong involvement of injury repair processes.
Malas TB; Formica C; Leonhard WN; Rao P; Granchi Z; Roos M; Peters DJ; 't Hoen PA
Am J Physiol Renal Physiol; 2017 Apr; 312(4):F806-F817. PubMed ID: 28148532
[TBL] [Abstract][Full Text] [Related]
3. RNA helicase p68 inhibits the transcription and post-transcription of
Zhang L; Li LX; Zhou JX; Harris PC; Calvet JP; Li X
Theranostics; 2020; 10(18):8281-8297. PubMed ID: 32724471
[No Abstract] [Full Text] [Related]
4. Pkd2 Deficiency in Embryonic Aqp2 + Progenitor Cells Is Sufficient to Cause Severe Polycystic Kidney Disease.
Tsilosani A; Gao C; Chen E; Lightle AR; Shehzad S; Sharma M; Tran PV; Bates CM; Wallace DP; Zhang W
J Am Soc Nephrol; 2024 Apr; 35(4):398-409. PubMed ID: 38254271
[TBL] [Abstract][Full Text] [Related]
5. Scattered Deletion of PKD1 in Kidneys Causes a Cystic Snowball Effect and Recapitulates Polycystic Kidney Disease.
Leonhard WN; Zandbergen M; Veraar K; van den Berg S; van der Weerd L; Breuning M; de Heer E; Peters DJ
J Am Soc Nephrol; 2015 Jun; 26(6):1322-33. PubMed ID: 25361818
[TBL] [Abstract][Full Text] [Related]
6. Metformin improves relevant disease parameters in an autosomal dominant polycystic kidney disease mouse model.
Pastor-Soler NM; Li H; Pham J; Rivera D; Ho PY; Mancino V; Saitta B; Hallows KR
Am J Physiol Renal Physiol; 2022 Jan; 322(1):F27-F41. PubMed ID: 34806449
[TBL] [Abstract][Full Text] [Related]
7. Metabolic reprogramming in a slowly developing orthologous model of polycystic kidney disease.
Hopp K; Kleczko EK; Gitomer BY; Chonchol M; Klawitter J; Christians U; Klawitter J
Am J Physiol Renal Physiol; 2022 Mar; 322(3):F258-F267. PubMed ID: 35037466
[TBL] [Abstract][Full Text] [Related]
8. Identification of pathological transcription in autosomal dominant polycystic kidney disease epithelia.
Friedrich S; Müller H; Riesterer C; Schüller H; Friedrich K; Wörner CL; Busch T; Viau A; Kuehn EW; Köttgen M; Hofherr A
Sci Rep; 2021 Jul; 11(1):15139. PubMed ID: 34301992
[TBL] [Abstract][Full Text] [Related]
9. Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease.
Li LX; Fan LX; Zhou JX; Grantham JJ; Calvet JP; Sage J; Li X
J Clin Invest; 2017 Jun; 127(7):2751-2764. PubMed ID: 28604386
[TBL] [Abstract][Full Text] [Related]
10. Curcumin inhibits cystogenesis by simultaneous interference of multiple signaling pathways: in vivo evidence from a Pkd1-deletion model.
Leonhard WN; van der Wal A; Novalic Z; Kunnen SJ; Gansevoort RT; Breuning MH; de Heer E; Peters DJ
Am J Physiol Renal Physiol; 2011 May; 300(5):F1193-202. PubMed ID: 21345977
[TBL] [Abstract][Full Text] [Related]
11. Altered Hippo signalling in polycystic kidney disease.
Happé H; van der Wal AM; Leonhard WN; Kunnen SJ; Breuning MH; de Heer E; Peters DJ
J Pathol; 2011 May; 224(1):133-42. PubMed ID: 21381034
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA
Aboudehen K; Farahani S; Kanchwala M; Chan SC; Avdulov S; Mickelson A; Lee D; Gearhart MD; Patel V; Xing C; Igarashi P
J Biol Chem; 2018 Jun; 293(24):9388-9398. PubMed ID: 29716997
[TBL] [Abstract][Full Text] [Related]
13. Renal expression of JAK2 is high in polycystic kidney disease and its inhibition reduces cystogenesis.
Patera F; Cudzich-Madry A; Huang Z; Fragiadaki M
Sci Rep; 2019 Mar; 9(1):4491. PubMed ID: 30872773
[TBL] [Abstract][Full Text] [Related]
14. Prioritized polycystic kidney disease drug targets and repurposing candidates from pre-cystic and cystic mouse Pkd2 model gene expression reversion.
Wilk EJ; Howton TC; Fisher JL; Oza VH; Brownlee RT; McPherson KC; Cleary HL; Yoder BK; George JF; Mrug M; Lasseigne BN
Mol Med; 2023 May; 29(1):67. PubMed ID: 37217845
[TBL] [Abstract][Full Text] [Related]
15. Four-jointed knock-out delays renal failure in an ADPKD model with kidney injury.
Formica C; Happé H; Veraar KA; Vortkamp A; Scharpfenecker M; McNeill H; Peters DJ
J Pathol; 2019 Sep; 249(1):114-125. PubMed ID: 31038742
[TBL] [Abstract][Full Text] [Related]
16. Cux1 promotes cell proliferation and polycystic kidney disease progression in an ADPKD mouse model.
Porath B; Livingston S; Andres EL; Petrie AM; Wright JC; Woo AE; Carlton CG; Baybutt R; Vanden Heuvel GB
Am J Physiol Renal Physiol; 2017 Oct; 313(4):F1050-F1059. PubMed ID: 28701314
[TBL] [Abstract][Full Text] [Related]
17. STAT5 drives abnormal proliferation in autosomal dominant polycystic kidney disease.
Fragiadaki M; Lannoy M; Themanns M; Maurer B; Leonhard WN; Peters DJ; Moriggl R; Ong AC
Kidney Int; 2017 Mar; 91(3):575-586. PubMed ID: 28104302
[TBL] [Abstract][Full Text] [Related]
18. Translational research in ADPKD: lessons from animal models.
Happé H; Peters DJ
Nat Rev Nephrol; 2014 Oct; 10(10):587-601. PubMed ID: 25137562
[TBL] [Abstract][Full Text] [Related]
19. The C-terminal tail of polycystin-1 regulates complement factor B expression by signal transducer and activator of transcription 1.
Wu M; Chen M; Jing Y; Gu J; Mei S; Yao Q; Zhou J; Yang M; Sun L; Wang W; Hu H; Wüthrich RP; Mei C
Am J Physiol Renal Physiol; 2016 Jun; 310(11):F1284-94. PubMed ID: 26984954
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease.
Seeger-Nukpezah T; Proia DA; Egleston BL; Nikonova AS; Kent T; Cai KQ; Hensley HH; Ying W; Chimmanamada D; Serebriiskii IG; Golemis EA
Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12786-91. PubMed ID: 23858461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
